Keywords: LEO Pharma, Virobay, License, Psoriasis

LEO Pharma in over $300 million deal for psoriasis therapy

Article | 10 January 2012

Print This

Privately-held Danish drugmaker LEO Pharma A/S has signed a multi-million dollar in-licensing deal with the US biotech company Virobay ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in